Endo - I wouldn't use the word "works". It is highly likely that BAVI/ anti-PS targeting has an effect on the immune system that is consistent with better patient outcomes. The degree and breadth of application is of course in question. Hopefully the data on the 10th at least sheds some light on those topics.
To be honest. There are multiple proofs that Bavi works.
In animals and early stage. Problem is there are multiple later stage proofs that it does not. which do you think are more important to bring a drug tomarket?
Market Data 
Markets 
AI
